Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.066 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.059 | 0.7 |